It has been a busy few weeks for the FDA, with plenty of big-name approvals and recalls making the news, but there have also been some other big announcements related to solutions receiving FDA clearance. 

Ami Bhatt, MD, the American College of Cardiology (ACC) chief innovation officer and adult congenital heart disease cardiologist at Mass General Hospital, discusses how to get physician acceptance to use artificial intelligence (AI). 

However, researchers noted, there was still a clear improvement in stroke risk.

The devices, currently being investigated by teams of heart specialists, could make a big impact in the years ahead. 

The study's authors compared findings from the PROTECT-AF and PREVAIL clinical trials with data from the NCDR LAAO Registry, focusing on short-term and long-term outcomes. 

A late-breaking study at Heart Rhythm 2022 found epicardial ablation in Brugada syndrome helped significantly reduce sudden cardiac arrest in these patients, increasing their survival.

The patient wears the device while the machine essentially operates itself.

Of the 51 plans, just 31% were consistent with the USPSTF recommendations pertaining to the starting age and frequency of screening women who are at average risk of developing breast cancer.